Vitamin E or probucol as donors for oxidation of human low-density lipoprotein by peroxidases/H2O2. 1994

S Braun, and F von Bruchhausen
Institute of Pharmacology, Universitätsklinikum Rudolf Virchow, Free University, Berlin, Germany.

Horseradish peroxidase or myeloperoxidase and H2O2 oxidize human low-density lipoprotein (LDL) in the presence or absence of a xenobiotic donor without an essential lag phase as revealed by an increase in the absorption at 234 nm. In the latter case, natural antioxidants like vitamin E and congeners serve as donor; radical formation by the action of peroxidase has been described before. Otherwise trolox C or probucol have donor function in this system. After oxidation by peroxidase/H2O2 LDL showed the expected reduced antioxidant capacity against vitamin-E-consuming radicals.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010544 Peroxidases Ovoperoxidase
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

S Braun, and F von Bruchhausen
October 1999, Atherosclerosis,
S Braun, and F von Bruchhausen
February 1993, Biochemical pharmacology,
S Braun, and F von Bruchhausen
February 1996, Free radical research,
S Braun, and F von Bruchhausen
June 1995, The Journal of clinical investigation,
S Braun, and F von Bruchhausen
November 1994, European journal of clinical investigation,
S Braun, and F von Bruchhausen
January 1991, The American journal of clinical nutrition,
S Braun, and F von Bruchhausen
September 2020, Free radical research,
S Braun, and F von Bruchhausen
September 1996, Atherosclerosis,
Copied contents to your clipboard!